Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1

Author： Naldini A. Carney D.H. Pucci A. Pasquali A. Carraro F.

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.35, Iss.5, 2000-11, pp. : 255-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vorapaxar: a novel protease-activated receptor-1 inhibitor

By Gurbel Paul A Jeong Young-Hoon Tantry Udaya S

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1445-1453

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of protease-activated receptor-1 antagonists

By Derian Claudia K Maryanoff Bruce E Zhang Han-Cheng Andrade-Gordon Patricia

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 209-221

Informa Healthcare

Access to resources Recommend Favorite

Suppression by protease-activated receptor-2 activation of gastric acid secretion in rats

By Nishikawa H. Kawai K. Nishimura S. Tanaka S. Araki H. Al-Ani B. Hollenberg M.D. Kuroda R. Kawabata A.

European Journal of Pharmacology, Vol. 447, Iss. 1, 2002-06 ,pp. : 87-90

Elsevier

Access to resources Recommend Favorite

Pharmacological characterization of protease-activated receptor (PAR-1) in rat astrocytes

By Debeir T. Vige X. Benavides J.

European Journal of Pharmacology, Vol. 323, Iss. 1, 1997-03 ,pp. : 111-117

Elsevier

Access to resources Recommend Favorite

Allosteric Modulation of Protease-Activated Receptor Signaling

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-08 ,pp. : 804-811

Bentham Science Publishers

Access to resources Recommend Favorite